Indian Journal of Dermatology
  Publication of IADVL, WB
  Official organ of AADV
Indexed with Science Citation Index (E) , Web of Science and PubMed
Users online: 2045  
Home About  Editorial Board  Current Issue Archives Online Early Coming Soon Guidelines Subscriptions  e-Alerts    Login  
    Small font sizeDefault font sizeIncrease font size Print this page Email this page
Year : 1989  |  Volume : 34  |  Issue : 2  |  Page : 32-41

'Dhat' syndrome-a useful clinical entity

Department of Psychiatry, Lady Harding Medical College and Associated Smt. Sucheta Kriplani Hospital New Delhi 110001

Correspondence Address:
MS Bhatia
Department of Psychiatry, Lady Harding Medical College and Associated Smt. Sucheta Kriplani Hospital New Delhi 110001

Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions

ABSTRACT: 48 consecutive male patients of potency disorders were examined and classified as 'Dhat' syndrome, impotence or premature ejaculation. The age range of these cases was found as 20-38 years (mean 23.5 plus minus 3.3 years) while age of onset was 16-24 years (mean 20.6 plus minus 4.5 years). Majority of cases were unmarried (54.2 percent) and educated 5th class or above (79.1 percent). 31 cases (64.6 percent) had Dhat syndrome with or without impotency and/or premature ejaculation while 7 cases (14.6 percent) had only premature ejaculation and 10 cases (20.8 percent) only impotence. The cases with 'Dhat' syndrome or with impotence scored maximally on neuroticism and depression scales. Neurotic depression was the commonest associated psychiatric illness (39.5 percent) followed by anxiety neurosis (20.8 percent) while 31.3 percent did not have any possible diagnosis. The common presenting symptoms of 'Dhat' syndrome include weakness (70.8 percent), fatigue (68.7 percent), palpitations (68.7 percent), sleeplessness (62.4 percent) etc. Among the four groups on the basis of type of treatment (antianxiety drug, antidepressant, placebo, psychotherapy), the best response was seen in those receiving antianxiety or antidepressant drugs while those receiving psychotherapy showed minimal response. 7 cases (14.6 percent) dropped out of treatment and the maximum dropout (40.6 percent) was seen in psychotherapy group.

[PDF Not available]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded0    
    Comments [Add]    
    Cited by others 8    

Recommend this journal